127 related articles for article (PubMed ID: 31764615)
1. Peptidylarginine Deiminase 2 Knockout Improves Survival in hemorrhagic shock.
Zhou J; Biesterveld BE; Li Y; Wu Z; Tian Y; Williams AM; Tian S; Gao W; Bhatti UF; Duan X; Wang T; Zhang J; Jiang B; Wang Z; Alam HB
Shock; 2020 Oct; 54(4):458-463. PubMed ID: 31764615
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of peptidylarginine deiminase attenuates inflammation and improves survival in a rat model of hemorrhagic shock.
He W; Zhou P; Chang Z; Liu B; Liu X; Wang Y; Li Y; Alam HB
J Surg Res; 2016 Feb; 200(2):610-8. PubMed ID: 26434505
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PAD2 Improves Survival in a Mouse Model of Lethal LPS-Induced Endotoxic Shock.
Wu Z; Deng Q; Pan B; Alam HB; Tian Y; Bhatti UF; Liu B; Mondal S; Thompson PR; Li Y
Inflammation; 2020 Aug; 43(4):1436-1445. PubMed ID: 32239392
[TBL] [Abstract][Full Text] [Related]
4. Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis.
Tian Y; Qu S; Alam HB; Williams AM; Wu Z; Deng Q; Pan B; Zhou J; Liu B; Duan X; Ma J; Mondal S; Thompson PR; Stringer KA; Standiford TJ; Li Y
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 33055424
[TBL] [Abstract][Full Text] [Related]
5. Peptidylarginine Deiminases 2 Mediates Caspase-1-Associated Lethality in Pseudomonas aeruginosa Pneumonia-Induced Sepsis.
Wu Z; Tian Y; Alam HB; Li P; Duan X; Williams AM; Liu B; Ma J; Li Y
J Infect Dis; 2021 Mar; 223(6):1093-1102. PubMed ID: 32729925
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
7. Delayed puberty, gonadotropin abnormalities and subfertility in male Padi2/Padi4 double knockout mice.
Sams KL; Mukai C; Marks BA; Mittal C; Demeter EA; Nelissen S; Grenier JK; Tate AE; Ahmed F; Coonrod SA
Reprod Biol Endocrinol; 2022 Oct; 20(1):150. PubMed ID: 36224627
[TBL] [Abstract][Full Text] [Related]
8. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice.
van Beers JJ; Zendman AJ; Raijmakers R; Stammen-Vogelzangs J; Pruijn GJ
Biochimie; 2013 Feb; 95(2):299-308. PubMed ID: 23026755
[TBL] [Abstract][Full Text] [Related]
9. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
Wang Y; Chen R; Gan Y; Ying S
Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
[TBL] [Abstract][Full Text] [Related]
10. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
Front Immunol; 2021; 12():716250. PubMed ID: 34737738
[TBL] [Abstract][Full Text] [Related]
11. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure.
Damiana T; Damgaard D; Sidelmann JJ; Nielsen CH; de Maat MPM; Münster AB; Palarasah Y
Clin Chim Acta; 2020 Feb; 501():6-11. PubMed ID: 31730822
[TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses.
Mergaert AM; Denny MF; Kingstad-Bakke B; Bawadekar M; Bashar SJ; Warner TF; Suresh M; Shelef MA
J Immunol Res; 2022; 2022():5258221. PubMed ID: 35083342
[TBL] [Abstract][Full Text] [Related]
13. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
[TBL] [Abstract][Full Text] [Related]
14. Wild-type p53-induced Phosphatase 1 Deficiency Exacerbates Myocardial Infarction-induced Ischemic Injury.
Liu KM; Zhang HH; Wang YN; Wang LM; Chen HY; Long CF; Zhang LF; Zhang HB; Yan HB
Chin Med J (Engl); 2017 Jun; 130(11):1333-1341. PubMed ID: 28524834
[TBL] [Abstract][Full Text] [Related]
15. PAD2-Mediated Citrullination Contributes to Efficient Oligodendrocyte Differentiation and Myelination.
Falcão AM; Meijer M; Scaglione A; Rinwa P; Agirre E; Liang J; Larsen SC; Heskol A; Frawley R; Klingener M; Varas-Godoy M; Raposo AASF; Ernfors P; Castro DS; Nielsen ML; Casaccia P; Castelo-Branco G
Cell Rep; 2019 Apr; 27(4):1090-1102.e10. PubMed ID: 31018126
[TBL] [Abstract][Full Text] [Related]
16. Compromised Anti-inflammatory Action of Neutrophil Extracellular Traps in PAD4-Deficient Mice Contributes to Aggravated Acute Inflammation After Myocardial Infarction.
Eghbalzadeh K; Georgi L; Louis T; Zhao H; Keser U; Weber C; Mollenhauer M; Conforti A; Wahlers T; Paunel-Görgülü A
Front Immunol; 2019; 10():2313. PubMed ID: 31632398
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of peptidylarginine deiminase alleviates LPS-induced pulmonary dysfunction and improves survival in a mouse model of lethal endotoxemia.
Liang Y; Pan B; Alam HB; Deng Q; Wang Y; Chen E; Liu B; Tian Y; Williams AM; Duan X; Wang Y; Zhang J; Li Y
Eur J Pharmacol; 2018 Aug; 833():432-440. PubMed ID: 29981294
[TBL] [Abstract][Full Text] [Related]
18. Murine Retinal Citrullination Declines With Age and is Mainly Dependent on Peptidyl Arginine Deiminase 4 (PAD4).
Hollingsworth TJ; Radic MZ; Beranova-Giorgianni S; Giorgianni F; Wang Y; Iannaccone A
Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):3808-3815. PubMed ID: 30073354
[TBL] [Abstract][Full Text] [Related]
19. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
20. PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.
Choudhury RH; Symonds P; Paston SJ; Daniels I; Cook KW; Gijon M; Metheringham RL; Brentville VA; Durrant LG
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35140112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
